Cycle Capital
Cycle Capital
Type of Funding
Venture Capital
Max Funding
N/A
Region
Federal/National
Application Difficuty
Fairly simple
Processing Time
Slow (A few months)
Province
All Of Canada
Industry
Business/Scientific and other professional services.
Funding Goals
Start-up Funding.
Demographic
N/A
Incorporated
No
Contact
514 495-1022
Apply For A Loan
Business location – Canada
Monthly Revenue – $10K +
Time in Business – 6 months +
Funds in 24 hours
$10,000 to $800,000
Details
Cycle Capital is a pioneer in Canadian Cleantech venture capital fund management investing in companies at the development and commercialization stages in North America. Founded in 2009 by Andrée-Lise Méthot, Founder and Managing Partner, Cycle Capitals Platform has become an important venture capital investor of the Cleantech industry with its 3 funds totaling $230M Assets Under Management (AUM).
Eligibility
Development Stage
Similar funding programs
Venture Capital
Skypoint venture capital funds provide early-stage equity to new or growing businesses with the potential to become major enterprises in telecommunications and information technology. Far reaching experience, mentorship expertise and industry insight give Skypoint Capital a unique and gainful power of recognition.
Max Funding N/A
Skypoint Capital
Venture Capital
York Angels provides a supportive linkage between local entrepreneurs, seeking early and mid-stage capital, and investors with a commitment to the economic development of the Region and to the entrepreneurial spirit of their community.
The York Angels seek investment opportunities where in the investee companies have excellent management and products and/or services that promise to have a sustainable competitive advantage.
Max Funding N/A
York Angel Investors
Venture Capital
Based in Montréal, CTI Life Sciences, a Canadian venture firm makes venture capital investments in high quality emerging life sciences companies at the pre-clinical and clinical development stage in Canada and in the U.S.
CTI Life Sciences currently manage $245 million of assets.
Max Funding N/A
CTI Life Sciences